已发表论文

血浆 N 端脑钠肽前体对 COPD 急性加重期并发左心衰竭的老年患者的诊断作用

 

Authors Guo X, Nie H, Chen Q, Chen S, Deng N, Li R, Ding X, Hu S, Wang A

Received 5 February 2018

Accepted for publication 17 July 2018

Published 21 September 2018 Volume 2018:13 Pages 2931—2940

DOI https://doi.org/10.2147/COPD.S164671

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Andrew Yee

Peer reviewer comments 3

Editor who approved publication: Professor Chunxue Bai

Introduction: Acute exacerbation of COPD (AECOPD) and left heart failure (LHF) commonly exist together in clinical practice. However, the identification of AECOPD concurrent with LHF is currently challenging. Our study aimed to investigate the role of plasma N-terminal brain natriuretic pro-peptide (NT-proBNP) in diagnosing elderly patients with AECOPD associated with LHF.
Methods and results: LHF was diagnosed in patients with AECOPD according to echocardiographic criteria, and the levels of NT-proBNP in plasma were measured by quantitative electrochemiluminescence assay. Among the 655 patients with AECOPD, 158 (24.1%) had comorbid LHF, whether systolic (n=108, 68.4%) or diastolic (n=50, 31.6%). The plasma concentrations of NT-proBNP in elderly patients with AECOPD associated with LHF were markedly elevated, compared with those with only AECOPD (4,542.5 and 763.0 ng/L, respectively, <0.01). The receiver operating characteristic curve indicated a diagnostic cutoff value of 1,677.5 ng/L of NT-proBNP in plasma for ascertaining the presence of LHF in AECOPD, with a sensitivity of 87.9%, a specificity of 88.5%, and an accuracy of 88.4%.
Conclusion: The plasma level of NT-proBNP may be a useful indicator in diagnosing AECOPD associated with LHF.
Keywords: COPD, exacerbation, left heart failure, NT-proBNP




Figure 2 The comorbidities of LH F in 158 patients with acute exacerbation of COPD.